APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genome Annotation Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Genome Annotation Service Market Outlook and Growth Opportunities 2026

3 May 2026194 pages

Choose your research edition.

Industry ResearchGenome Annotation Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Genome Annotation Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Genome Annotation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genome Annotation Service Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Genome Annotation Service Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Genome Annotation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Genome Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genome Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genome Annotation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Genome Annotation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Genome Annotation Service market include Charles River, Lexogen, Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp and Berry Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Genome Annotation Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genome Annotation Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genome Annotation Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Genome Annotation Service market.

Genome Annotation Service Segment by Company

Charles River

Lexogen

Eurofins Scientific

Natera

BGI

Illumina

Roche

LabCorp

Berry Genomics

Brooks Life Sciences

Macrogen

Personalis

Novogene

Genotypic Technology

Dna Link

Genome Annotation Service Segment by Type

RAST Tool Kit

Viral Genome ORF Reader

Genome Annotation Service Segment by Application

Hospitals and Clinics

Biopharma Companies

Academic & Research Organizations

Others

Genome Annotation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Genome Annotation Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Genome Annotation Service key companies, revenue, market share, and recent developments.

3. To split the Genome Annotation Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Genome Annotation Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Genome Annotation Service significant trends, drivers, influence factors in global and regions.

6. To analyze Genome Annotation Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Annotation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genome Annotation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Annotation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genome Annotation Service industry.

Chapter 3: Detailed analysis of Genome Annotation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Genome Annotation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Genome Annotation Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Genome Annotation Service Industry Trends Table 2. Genome Annotation Service Industry Drivers Table 3. Genome Annotation Service Industry Opportunities and Challenges Table 4. Genome Annotation Service Industry Restraints Table 5. Global Genome Annotation Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Genome Annotation Service Revenue Share by Company (2021-2026) Table 7. Global Genome Annotation Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Genome Annotation Service Key Company Manufacturing Base & Headquarters Table 9. Global Genome Annotation Service Company, Product Type & Application Table 10. Global Genome Annotation Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Genome Annotation Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of RAST Tool Kit Table 15. Significant Companies of Viral Genome ORF Reader Table 16. Global Genome Annotation Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Genome Annotation Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Genome Annotation Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Genome Annotation Service Sales Value Share by Type (2021-2026) Table 20. Global Genome Annotation Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals and Clinics Table 22. Significant Companies of Biopharma Companies Table 23. Significant Companies of Academic & Research Organizations Table 24. Significant Companies of Others Table 25. Global Genome Annotation Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Genome Annotation Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Genome Annotation Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Genome Annotation Service Sales Value Share by Application (2021-2026) Table 29. Global Genome Annotation Service Sales Value Share by Application (2027-2032) Table 30. Global Genome Annotation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Genome Annotation Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Genome Annotation Service Sales Value Share by Region (2021-2026) Table 33. Global Genome Annotation Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Genome Annotation Service Sales Value Share by Region (2027-2032) Table 35. Global Genome Annotation Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Genome Annotation Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Genome Annotation Service Sales Value Market Share by Country (2021-2026) Table 38. Global Genome Annotation Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Genome Annotation Service Sales Value Market Share by Country (2027-2032) Table 40. Charles River Company Information Table 41. Charles River Business Overview Table 42. Charles River Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Charles River Genome Annotation Service Product Portfolio Table 44. Charles River Recent Development Table 45. Lexogen Company Information Table 46. Lexogen Business Overview Table 47. Lexogen Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Lexogen Genome Annotation Service Product Portfolio Table 49. Lexogen Recent Development Table 50. Eurofins Scientific Company Information Table 51. Eurofins Scientific Business Overview Table 52. Eurofins Scientific Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Eurofins Scientific Genome Annotation Service Product Portfolio Table 54. Eurofins Scientific Recent Development Table 55. Natera Company Information Table 56. Natera Business Overview Table 57. Natera Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Natera Genome Annotation Service Product Portfolio Table 59. Natera Recent Development Table 60. BGI Company Information Table 61. BGI Business Overview Table 62. BGI Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. BGI Genome Annotation Service Product Portfolio Table 64. BGI Recent Development Table 65. Illumina Company Information Table 66. Illumina Business Overview Table 67. Illumina Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Illumina Genome Annotation Service Product Portfolio Table 69. Illumina Recent Development Table 70. Roche Company Information Table 71. Roche Business Overview Table 72. Roche Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Roche Genome Annotation Service Product Portfolio Table 74. Roche Recent Development Table 75. LabCorp Company Information Table 76. LabCorp Business Overview Table 77. LabCorp Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. LabCorp Genome Annotation Service Product Portfolio Table 79. LabCorp Recent Development Table 80. Berry Genomics Company Information Table 81. Berry Genomics Business Overview Table 82. Berry Genomics Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Berry Genomics Genome Annotation Service Product Portfolio Table 84. Berry Genomics Recent Development Table 85. Brooks Life Sciences Company Information Table 86. Brooks Life Sciences Business Overview Table 87. Brooks Life Sciences Genome Annotation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Brooks Life Sciences Genome Annotation Service Product Portfolio Table 89. Brooks Life Sciences Recent Development Table 90. Macrogen Company Information Table 91. Macrogen Business Overview Table 92. Macrogen Genome Annotation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Macrogen Genome Annotation Service Product Portfolio Table 94. Macrogen Recent Development Table 95. Personalis Company Information Table 96. Personalis Business Overview Table 97. Personalis Genome Annotation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Personalis Genome Annotation Service Product Portfolio Table 99. Personalis Recent Development Table 100. Novogene Company Information Table 101. Novogene Business Overview Table 102. Novogene Genome Annotation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Novogene Genome Annotation Service Product Portfolio Table 104. Novogene Recent Development Table 105. Genotypic Technology Company Information Table 106. Genotypic Technology Business Overview Table 107. Genotypic Technology Genome Annotation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Genotypic Technology Genome Annotation Service Product Portfolio Table 109. Genotypic Technology Recent Development Table 110. Dna Link Company Information Table 111. Dna Link Business Overview Table 112. Dna Link Genome Annotation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Dna Link Genome Annotation Service Product Portfolio Table 114. Dna Link Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Genome Annotation Service Product Image Figure 2. Global Genome Annotation Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genome Annotation Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Genome Annotation Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. RAST Tool Kit Image Figure 8. Viral Genome ORF Reader Image Figure 9. Global Genome Annotation Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Genome Annotation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Genome Annotation Service Sales Value Share by Type (2021-2032) Figure 12. Hospitals and Clinics Image Figure 13. Biopharma Companies Image Figure 14. Academic & Research Organizations Image Figure 15. Others Image Figure 16. Global Genome Annotation Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Genome Annotation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Genome Annotation Service Sales Value Share by Application (2021-2032) Figure 19. Global Genome Annotation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Genome Annotation Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Genome Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Genome Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Genome Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Genome Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Genome Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Genome Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Genome Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Genome Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Genome Annotation Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Genome Annotation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Genome Annotation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Genome Annotation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Genome Annotation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • RAST Tool Kit
  • Viral Genome ORF Reader
Applications
  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others
Companies covered
  • Charles River
  • Lexogen
  • Eurofins Scientific
  • Natera
  • BGI
  • Illumina
  • Roche
  • LabCorp
  • Berry Genomics
  • Brooks Life Sciences
  • Macrogen
  • Personalis
  • Novogene
  • Genotypic Technology
  • Dna Link

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genome Annotation Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genome Annotation Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Genome Annotation Service Market Dynamics
  1. 2.1 Genome Annotation Service Industry Trends
  2. 2.2 Genome Annotation Service Industry Drivers
  3. 2.3 Genome Annotation Service Industry Opportunities and Challenges
  4. 2.4 Genome Annotation Service Industry Restraints
3 Genome Annotation Service Market by Company
  1. 3.1 Global Genome Annotation Service Company Revenue Ranking in 2025
  2. 3.2 Global Genome Annotation Service Revenue by Company (2021-2026)
  3. 3.3 Global Genome Annotation Service Company Ranking (2024-2026)
  4. 3.4 Global Genome Annotation Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Genome Annotation Service Company Product Type and Application
  6. 3.6 Global Genome Annotation Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Genome Annotation Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Genome Annotation Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Genome Annotation Service Market by Type
  1. 4.1 Genome Annotation Service Type Introduction
  2. 4.1.1 RAST Tool Kit
  3. 4.1.2 Viral Genome ORF Reader
  4. 4.2 Global Genome Annotation Service Sales Value by Type
  5. 4.2.1 Global Genome Annotation Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Genome Annotation Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Genome Annotation Service Sales Value Share by Type (2021-2032)
5 Genome Annotation Service Market by Application
  1. 5.1 Genome Annotation Service Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Biopharma Companies
  4. 5.1.3 Academic & Research Organizations
  5. 5.1.4 Others
  6. 5.2 Global Genome Annotation Service Sales Value by Application
  7. 5.2.1 Global Genome Annotation Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Genome Annotation Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Genome Annotation Service Sales Value Share by Application (2021-2032)
6 Genome Annotation Service Regional Value Analysis
  1. 6.1 Global Genome Annotation Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genome Annotation Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Genome Annotation Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Genome Annotation Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genome Annotation Service Sales Value (2021-2032)
  7. 6.3.2 North America Genome Annotation Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Genome Annotation Service Sales Value (2021-2032)
  10. 6.4.2 Europe Genome Annotation Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Genome Annotation Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Genome Annotation Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Genome Annotation Service Sales Value (2021-2032)
  16. 6.6.2 South America Genome Annotation Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Genome Annotation Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Genome Annotation Service Sales Value Share by Country, 2025 VS 2032
7 Genome Annotation Service Country-level Value Analysis
  1. 7.1 Global Genome Annotation Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Genome Annotation Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Genome Annotation Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Genome Annotation Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Genome Annotation Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Genome Annotation Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Genome Annotation Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Genome Annotation Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Genome Annotation Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Genome Annotation Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Genome Annotation Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Genome Annotation Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Genome Annotation Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Genome Annotation Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Genome Annotation Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Genome Annotation Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Genome Annotation Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Genome Annotation Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Genome Annotation Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Genome Annotation Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Genome Annotation Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Genome Annotation Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Genome Annotation Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Genome Annotation Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Genome Annotation Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Genome Annotation Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Genome Annotation Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Genome Annotation Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Genome Annotation Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Genome Annotation Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Genome Annotation Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Genome Annotation Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Genome Annotation Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Genome Annotation Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River
  2. 8.1.1 Charles River Company Information
  3. 8.1.2 Charles River Business Overview
  4. 8.1.3 Charles River Genome Annotation Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Genome Annotation Service Product Portfolio
  6. 8.1.5 Charles River Recent Developments
  7. 8.2 Lexogen
  8. 8.2.1 Lexogen Company Information
  9. 8.2.2 Lexogen Business Overview
  10. 8.2.3 Lexogen Genome Annotation Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lexogen Genome Annotation Service Product Portfolio
  12. 8.2.5 Lexogen Recent Developments
  13. 8.3 Eurofins Scientific
  14. 8.3.1 Eurofins Scientific Company Information
  15. 8.3.2 Eurofins Scientific Business Overview
  16. 8.3.3 Eurofins Scientific Genome Annotation Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Scientific Genome Annotation Service Product Portfolio
  18. 8.3.5 Eurofins Scientific Recent Developments
  19. 8.4 Natera
  20. 8.4.1 Natera Company Information
  21. 8.4.2 Natera Business Overview
  22. 8.4.3 Natera Genome Annotation Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Natera Genome Annotation Service Product Portfolio
  24. 8.4.5 Natera Recent Developments
  25. 8.5 BGI
  26. 8.5.1 BGI Company Information
  27. 8.5.2 BGI Business Overview
  28. 8.5.3 BGI Genome Annotation Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BGI Genome Annotation Service Product Portfolio
  30. 8.5.5 BGI Recent Developments
  31. 8.6 Illumina
  32. 8.6.1 Illumina Company Information
  33. 8.6.2 Illumina Business Overview
  34. 8.6.3 Illumina Genome Annotation Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Illumina Genome Annotation Service Product Portfolio
  36. 8.6.5 Illumina Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche Genome Annotation Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roche Genome Annotation Service Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 LabCorp
  44. 8.8.1 LabCorp Company Information
  45. 8.8.2 LabCorp Business Overview
  46. 8.8.3 LabCorp Genome Annotation Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LabCorp Genome Annotation Service Product Portfolio
  48. 8.8.5 LabCorp Recent Developments
  49. 8.9 Berry Genomics
  50. 8.9.1 Berry Genomics Company Information
  51. 8.9.2 Berry Genomics Business Overview
  52. 8.9.3 Berry Genomics Genome Annotation Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Berry Genomics Genome Annotation Service Product Portfolio
  54. 8.9.5 Berry Genomics Recent Developments
  55. 8.10 Brooks Life Sciences
  56. 8.10.1 Brooks Life Sciences Company Information
  57. 8.10.2 Brooks Life Sciences Business Overview
  58. 8.10.3 Brooks Life Sciences Genome Annotation Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Brooks Life Sciences Genome Annotation Service Product Portfolio
  60. 8.10.5 Brooks Life Sciences Recent Developments
  61. 8.11 Macrogen
  62. 8.11.1 Macrogen Company Information
  63. 8.11.2 Macrogen Business Overview
  64. 8.11.3 Macrogen Genome Annotation Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Macrogen Genome Annotation Service Product Portfolio
  66. 8.11.5 Macrogen Recent Developments
  67. 8.12 Personalis
  68. 8.12.1 Personalis Company Information
  69. 8.12.2 Personalis Business Overview
  70. 8.12.3 Personalis Genome Annotation Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Personalis Genome Annotation Service Product Portfolio
  72. 8.12.5 Personalis Recent Developments
  73. 8.13 Novogene
  74. 8.13.1 Novogene Company Information
  75. 8.13.2 Novogene Business Overview
  76. 8.13.3 Novogene Genome Annotation Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Novogene Genome Annotation Service Product Portfolio
  78. 8.13.5 Novogene Recent Developments
  79. 8.14 Genotypic Technology
  80. 8.14.1 Genotypic Technology Company Information
  81. 8.14.2 Genotypic Technology Business Overview
  82. 8.14.3 Genotypic Technology Genome Annotation Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Genotypic Technology Genome Annotation Service Product Portfolio
  84. 8.14.5 Genotypic Technology Recent Developments
  85. 8.15 Dna Link
  86. 8.15.1 Dna Link Company Information
  87. 8.15.2 Dna Link Business Overview
  88. 8.15.3 Dna Link Genome Annotation Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dna Link Genome Annotation Service Product Portfolio
  90. 8.15.5 Dna Link Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst